Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.
Wang, Xuemin
Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin. [electronic resource] - The Biochemical journal Oct 2002 - 475-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0264-6021
10.1042/BJ20020677 doi
Aminophenols--pharmacology
Animals
Butadienes--pharmacology
CHO Cells
Chromones--pharmacology
Cricetinae
Enzyme Inhibitors--pharmacology
Eukaryotic Initiation Factor-2B--drug effects
Glycogen Synthase Kinase 3--antagonists & inhibitors
Indoles--pharmacology
Insulin--metabolism
Lithium Chloride--pharmacology
Maleimides--pharmacology
Morpholines--pharmacology
Nitriles--pharmacology
Phosphatidylinositol 3-Kinases--metabolism
Phosphoinositide-3 Kinase Inhibitors
Phosphorylation
Protein Kinases--drug effects
Protein Subunits
Serine--metabolism
TOR Serine-Threonine Kinases
Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin. [electronic resource] - The Biochemical journal Oct 2002 - 475-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0264-6021
10.1042/BJ20020677 doi
Aminophenols--pharmacology
Animals
Butadienes--pharmacology
CHO Cells
Chromones--pharmacology
Cricetinae
Enzyme Inhibitors--pharmacology
Eukaryotic Initiation Factor-2B--drug effects
Glycogen Synthase Kinase 3--antagonists & inhibitors
Indoles--pharmacology
Insulin--metabolism
Lithium Chloride--pharmacology
Maleimides--pharmacology
Morpholines--pharmacology
Nitriles--pharmacology
Phosphatidylinositol 3-Kinases--metabolism
Phosphoinositide-3 Kinase Inhibitors
Phosphorylation
Protein Kinases--drug effects
Protein Subunits
Serine--metabolism
TOR Serine-Threonine Kinases